Entering text into the input field will update the search result below

SciSparc partners with Clearmind to develop psychedelic therapies

Mar. 08, 2022 2:22 PM ETSciSparc Ltd. (SPRC), CMNDBy: SA News Team
  • SciSparc (NASDAQ:SPRC) said it had collaborated with Clearmind Medicine (OTCPK:CMNDF) to explore the development of psychedelic-based therapies.
  • The companies, which have begun the collaboration with a joint pre-clinical study, said the psychedelic-centric drug candidates will target mental health-related diseases.
  • According to the Market

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.